Table 1 The reported occurrence of Corona virus infection, re-infection, and the vaccination status among the sample of educated Syrian participants in relation to their socio-demographic characteristics, 2021
| Â | Gender | Age | Education | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Male (%) | Female (%) |  < 20 (%) | 20–29 (%) | 30–40 (%) |  > 40 (%) | Middle School (%) | High School (%) | Graduates (%) | Postgraduate (%) | ||
Previous COVID-19 infection | |||||||||||
 Yes | 192 (47%) | 52 (46.4) | 140 (47.3) | 15 (34.1) | 63 (39.4) | 32 (43.8) | 82 (62.6) | 4 (40.0) | 16 (47.1) | 109 (45.0) | 63 (51.6) |
 Maybe | 157 (38.5%) | 41 (36.6) | 116 (39.2) | 16 (36.4) | 76 (47.5) | 30 (41.1) | 35 (26.7) | 5 (50.0) | 12 (35.3) | 95 (39.3) | 45 (36.9) |
 No | 59 (14.5%) | 19 (17.0) | 40 (13.5) | 13 (29.5) | 21 (13.1) | 11 (15.1) | 14 (10.7) | 1 (10.0) | 6 (17.6) | 38 (15.7) | 14 (11.5) |
 Total | 408 | 112 | 296 | 44 | 160 | 73 | 131 | 10 | 34 | 242 | 122 |
 Pearson Chi-Square P - value | 0.663 | < 0.001* | 0.834 | ||||||||
Recurrence of COVID-19 infection | |||||||||||
 Yes | 77 (20.1%) | 17 (17.0) | 60 (21.2) | 9 (23.7) | 31 (20.3) | 14 (20.3) | 23 (18.7) | 2 (22.2) | 7 (21.9) | 45 (20.0) | 23 (19.7) |
 Maybe | 104 (27.2%) | 29 (29.0) | 75 (26.5) | 7 (18.4) | 46 (30.1) | 18 (26.1) | 33 (26.8) | 4 (44.4) | 3 (9.4) | 53 (23.6) | 44 (37.6) |
 No | 202 (52.7%) | 54 (54.0) | 148 (52.3) | 22 (57.9) | 76 (49.7) | 37 (53.6) | 67 (54.5) | 3 (33.3) | 22 (68.8) | 127 (56.4) | 50 (42.7) |
 Total | 383a | 100 | 283 | 38 | 153 | 69 | 123 | 9 | 32 | 225 | 117 |
 Pearson Chi-Square P - value | 0.651 | 0.870 | 0.016* | ||||||||
Medical confirmation of COVID-19 infection | |||||||||||
 Yes | 120 (31.3%) | 38 (38.0) | 82 (29.0) | 6 (15.8) | 27 (17.6) | 27 (39.1) | 60 (48.8) | 3 (30.0) | 10 (31.3) | 62 (27.6) | 45 (38.8) |
 No | 263 (68.7%) | 62 (62.0) | 201 (71.0) | 32 (84.2) | 126 (82.4) | 42 (60.9) | 63 (51.2) | 7 (70.0) | 22 (68.8) | 163 (72.4) | 71 (61.2) |
 Total | 383a | 100 | 283 | 38 | 153 | 69 | 123 | 10 | 32 | 225 | 116 |
 Pearson Chi-Square P - value | 0.094 | < 0.001* | 0.212 | ||||||||
Vaccination against COVID-19 | |||||||||||
 Yes | 201 (49.3) | 63 (56.3) | 138 (46.6) | 7 (15.9) | 62 (38.8) | 47 (64.4) | 85 (64.9) | 0 (0.0) | 6 (17.6) | 114 (47.1) | 81 (66.4) |
 Not ready yet | 92 (22.5) | 18 (16.1) | 74 (25.0) | 14 (31.8) | 53 (33.1) | 9 (12.3) | 16 (12.2) | 4 (40.0) | 12 (35.3) | 59 (24.4) | 17 (13.9) |
 Never | 82 (20.1) | 21 (18.8) | 61 (20.6) | 15 (34.1) | 34 (21.3) | 12 (16.4) | 21 (16.0) | 5 (50.0) | 9 (26.5) | 50 (20.7) | 18 (14.8) |
 Neutral | 33 (8.1) | 10 (8.9) | 23 (7.8) | 8 (18.2) | 11 (6.9) | 5 (6.8) | 9 (6.9) | 1 (10.0) | 7 (20.6) | 19 (7.9) | 6 (4.9) |
 Total | 408 | 112 | 296 | 44 | 160 | 73 | 131 | 10 | 34 | 242 | 122 |
 Pearson Chi-Square P - value | 0.197 |  < 0.001* | 0.001* | ||||||||